Growth Equity Opportunities V LLC 13D and 13G filings for MEI Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-03-09 4:10 pm Sale |
2023-03-09 | 13D | MEI Pharma, Inc. MEIP |
Growth Equity Opportunities V LLC | 1 5.000% |
-498,160![]() (-100.00%) |
Filing |